Owner NovImmune SA

Inventors Elson, Greg Christopher Andrew

Agent Cullens

Pub. Number AU-B-2004311541

PCT Pub. Number WO2005/065015

Priority 60/528,812 10.12.03 US; 60/528,962 10.12.03 US; 60/528,811 10.12.03 US

Filing date 10 December 2004

Wipo publication date 21 July 2005

Acceptance publication date 30 June 2011

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12N 15/79 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for eukaryotic hosts

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine